Bothell, WA, United States of America
Alder Biopharmaceuticals, Inc.
Patents = 8
Trademarks = 1
Forward Citations = 97
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
62 inventors (with patents filed for the assignee):
Alder Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutic antibodies for the treatment of migraine. Their lead product candidate, eptinezumab, is in late-stage clinical development for the prevention of migraines.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com